Literature DB >> 3033057

Hepatic encephalopathy. Application of visual evoked responses to test hypotheses of its pathogenesis in rats.

D B Jones, K D Mullen, M Roessle, T Maynard, E A Jones.   

Abstract

A previous study of the patterns of visual evoked responses (VERs) in rats was interpreted as providing support for the synergistic neurotoxins hypothesis of the pathogenesis of hepatic encephalopathy (HE) due to fulminant hepatic failure (FHF). In contrast, other studies of the patterns of VERs in rabbits with different encephalopathies were interpreted as providing support for the concept that increased GABA-ergic tone may contribute to the neural inhibition of HE due to FHF. To attempt to resolve the discordant findings in these studies, additional studies of VERs have been undertaken in rats. To induce increased tissue levels of ammonia, mercaptans and fatty acids which are found in HE due to FHF, carefully predetermined doses of urease, dimethyldisulphide and octanoic acid were administered. The (pre-seizure) encephalopathy induced by these three agents was associated with abnormalities of the VER waveform that were fundamentally different from the abnormalities of the VER waveform associated with HE due to thioacetamide-induced FHF. However, the VER waveform in this model of HE due to FHF resembled closely that associated with pentobarbital-induced encephalopathy. These findings are in satisfactory agreement with those in the previous analogous studies in rabbits. They do not provide support for the synergistic neurotoxins hypothesis of the pathogenesis of HE, but are entirely consistent with increased GABA-ergic tone contributing to the neural inhibition of HE due to FHF.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033057     DOI: 10.1016/s0168-8278(87)80018-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

Review 1.  Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?

Authors:  E A Jones; A S Basile
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

2.  Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.

Authors:  J W Thomas; C Banner; J Whitman; K D Mullen; E Freese
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

3.  Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine.

Authors:  H L Hu; R D Chen
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

4.  Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.

Authors:  H P Meyer; D A Legemate; W van den Brom; J Rothuizen
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

Review 5.  Flumazenil in the treatment of portal systemic encephalopathy--an overview.

Authors:  K Gyr; R Meier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

6.  Gamma-aminobutyric acid (GABAA) receptor-function in a rat model of hepatic encephalopathy.

Authors:  B L Baker; A L Morrow; J Vergalla; S M Paul; E A Jones
Journal:  Metab Brain Dis       Date:  1990-12       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.